Creative Planning Meridian Bioscience Inc Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$18.01 - $28.32 $1.15 Million - $1.81 Million	-64,044 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$19.76 - $29.89 $118,895 - $179,848	6,017 Added 10.37%	64,044 $1.68 Million
Q4 2020 Jan 29, 2021	BUY	$15.73 - $21.66 $300,804 - $414,204	19,123 Added 49.15%	58,027 $1.09 Million
Q3 2020 Nov 05, 2020	BUY	$13.54 - $26.41 $526,760 - $1.03 Million	38,904 New	38,904 $661,000
Q4 2017 Jan 17, 2018	SELL	$13.55 - $15.8 $213,060 - $248,439	-15,724 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$13.45 - $14.35 $211,487 - $225,639	15,724	15,724 $225,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.